scientific name for retatrutide Triple Agonist (GLP-1/GIP/GCG) Retatrutide UK 2026: Phase 3

Can people with hypothyroidism take GLP-1 medications

Seven additional Phase 3 TRIUMPH trials are expected to report results throughout 2026, covering obesity, type 2 diabetes, sleep apnea, chronic low back pain, and metabolic liver disease (ClinicalTrials.gov)

- Motley Rice Case A 44-year-old woman was prescribed Ozempic during the summer months of 2022

The public conversation around Gwyneth Paltrow, Andrew Huberman, GLP-1s, and peptides has made more people aware of this emerging medication

For women with PCOS, weight reduction of 5-10% can significantly improve insulin sensitivity, reduce hyperandrogenism, and restore ovulatory cycles

1 In patients diagnosed with CKD, there were no statistically significant changes in creatinine associated with any of the three GLP-1 medications studied